6533b855fe1ef96bd12b1880

RESEARCH PRODUCT

Risk of disease decompensation and HCC in patients with HCV cirrhosis non responders to PEG IFN plus RBV

V CalvarusoMg BavettaD FerraroS GrimaudoE ConteRm PipitoneA CraxiV. Di Marco

subject

HCV HCC PEG IFN RBVhttp://hdl.handle.net/10447/247553